Patient population is about 145,000 annually...tar
Post# of 145440
![](/assets/46931549/no_avatar_available_thumb.jpg)
The company is CEL-SCI... the Cancer product Multikine is used for 3 weeks prior to surgery...apparently reduces size etc. and then SOC....trades at ten times our current value...they have had talks with Merck.
Ohm...your thoughts...not as an investment...but as a Cancer treatment.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)